Search research articles
Contact Us
Filters
Showing results (91-100 of 125) with videos related to
Page
of 13
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 11, 2017
Clinical significance of half-lives of tumor markers α-fetoprotein and des-γ-carboxy prothrombin after hepatectomy for hepatocellular carcinoma
Masayo Tsukamoto, Hidetoshi Nitta, Katsunori Imai, et al.
International Journal of Clinical Oncology
|
October 22, 2024
Prognostic impact of aspirin in patients with hepatocellular carcinoma after liver resection: propensity-score-matched analysis
Takashi Matsumoto, Yuki Kitano, Katsunori Imai, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
November 23, 2019
Ischemic Cholangiopathy Following Transcatheter Arterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy: an Underestimated and Devastating Complication
Shinichiro Nakada, Marc-Antoine Allard, Maite Lewin, et al.
Anticancer Research
|
October 3, 2014
Carcinoembryonic antigen half-life is an early predictor of therapeutic effects in induction chemotherapy for liver metastases from colorectal cancer
Yohei Nagai, Toru Beppu, Yasuo Sakamoto, et al.
World Journal of Surgery
|
January 2, 2021
Ideal Surgical Margin to Prevent Early Recurrence After Hepatic Resection for Hepatocellular Carcinoma
Hidetoshi Nitta, Marc-Antoine Allard, Mylène Sebagh, et al.
Gastrointestinal Tumors
|
October 12, 2019
Frailty Predicts Severe Postoperative Complication after Elective Hepatic Resection
Hirohisa Okabe, Hiromitsu Hayashi, Takaaki Higashi, et al.
Asian Journal of Endoscopic Surgery
|
September 14, 2019
Thoracoscopic surgery for hepatocellular carcinoma located in the hepatic dome: Technical aspect and oncological results
Takanobu Yamao, Katsunori Imai, Yo-Ichi Yamashita, et al.
International Journal of Clinical Oncology
|
March 13, 2017
Neutrophil-to-lymphocyte ratio predicts metachronous liver metastasis of pancreatic neuroendocrine tumors
Kota Arima, Hirohisa Okabe, Daisuke Hashimoto, et al.
Journal of Clinical and Translational Hepatology
|
June 30, 2017
The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma
Toru Beppu, Shigeki Nakagawa, Hidetoshi Nitta, et al.
Medical Oncology (Northwood, London, England)
|
October 14, 2016
Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma
Takaaki Higashi, Hiromitsu Hayashi, Yuki Kitano, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 125) with videos related to
Sort By:
Page
of 13
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 11, 2017
Clinical significance of half-lives of tumor markers α-fetoprotein and des-γ-carboxy prothrombin after hepatectomy for hepatocellular carcinoma
Masayo Tsukamoto, Hidetoshi Nitta, Katsunori Imai, et al.
International Journal of Clinical Oncology
|
October 22, 2024
Prognostic impact of aspirin in patients with hepatocellular carcinoma after liver resection: propensity-score-matched analysis
Takashi Matsumoto, Yuki Kitano, Katsunori Imai, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
November 23, 2019
Ischemic Cholangiopathy Following Transcatheter Arterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy: an Underestimated and Devastating Complication
Shinichiro Nakada, Marc-Antoine Allard, Maite Lewin, et al.
Anticancer Research
|
October 3, 2014
Carcinoembryonic antigen half-life is an early predictor of therapeutic effects in induction chemotherapy for liver metastases from colorectal cancer
Yohei Nagai, Toru Beppu, Yasuo Sakamoto, et al.
World Journal of Surgery
|
January 2, 2021
Ideal Surgical Margin to Prevent Early Recurrence After Hepatic Resection for Hepatocellular Carcinoma
Hidetoshi Nitta, Marc-Antoine Allard, Mylène Sebagh, et al.
Gastrointestinal Tumors
|
October 12, 2019
Frailty Predicts Severe Postoperative Complication after Elective Hepatic Resection
Hirohisa Okabe, Hiromitsu Hayashi, Takaaki Higashi, et al.
Asian Journal of Endoscopic Surgery
|
September 14, 2019
Thoracoscopic surgery for hepatocellular carcinoma located in the hepatic dome: Technical aspect and oncological results
Takanobu Yamao, Katsunori Imai, Yo-Ichi Yamashita, et al.
International Journal of Clinical Oncology
|
March 13, 2017
Neutrophil-to-lymphocyte ratio predicts metachronous liver metastasis of pancreatic neuroendocrine tumors
Kota Arima, Hirohisa Okabe, Daisuke Hashimoto, et al.
Journal of Clinical and Translational Hepatology
|
June 30, 2017
The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma
Toru Beppu, Shigeki Nakagawa, Hidetoshi Nitta, et al.
Medical Oncology (Northwood, London, England)
|
October 14, 2016
Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma
Takaaki Higashi, Hiromitsu Hayashi, Yuki Kitano, et al.
Page
of 13